Journal
JOURNAL OF HEPATOLOGY
Volume 61, Issue 6, Pages 1358-1364Publisher
ELSEVIER
DOI: 10.1016/j.jhep.2014.06.037
Keywords
Thyrotropin (TSH); Hepatic steatosis; Triglyceride; Sterol regulatory element-binding protein 1c; Peroxisome proliferator-activated receptor alpha
Categories
Funding
- National Basic Research Program [2012CB524900]
- National Natural Science Foundation [81230018, 30971409, 81471006, 81270869, 81300644, 81370891]
- Jinan self-renovation plan for colleges, universities and scientific research institutes of China
- Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province [BS2011SW034]
Ask authors/readers for more resources
Background & Aims: Hallmarks of non-alcoholic fatty liver disease (NAFLD) are increased triglyceride accumulation within hepatocytes. The prevalence of NAFLD increases steadily with increasing thyrotropin (TSH) levels. However, the underlying mechanisms are largely unknown. Here, we focused on exploring the effect and mechanism of TSH on the hepatic triglyceride content. Methods: As the function of TSH is mediated through the TSH receptor (TSHR), Tshr(-/-) mice (supplemented with thyroxine) were used. Liver steatosis and triglyceride content were analysed in Tshr(-/-) and Tshr(+/+) mice fed a high-fat or normal chow diet, as well as in Srebp-1c(-/-) and Tshr(-/-) Srebp-1c(-/-) mice. The expression levels of proteins and genes involved in liver triglyceride metabolism was measured. Results: Compared with control littermates, the high-fat diet induced a relatively low degree of liver steatosis in Tshr(-/-) mice. Even under chow diet, hepatic triglyceride content was decreased in Tshr(-/-) mice. TSH caused concentration-and time-dependent effects on intracellular triglyceride contents in hepatocytes in vitro. The activity of SREBP-1c, a key regulator involved in triglyceride metabolism and in the pathogenesis of NAFLD, was significantly lower in Tshr(-/-) mice. In Tshr(-/-) Srebp-1c(-/-) mice, the liver triglyceride content showed no significant difference compared with Tshr(+/+) Srebp-1c(-/-) mice. When mice were injected with forskolin (cAMP activator), H89 (inhibitor of PKA) or AICAR (AMPK activator), or HeG2 cells received MK886 (PPAR alpha inhibitor), triglyceride contents presented in a manner dependent on SREBP-1c activity. The mechanism, underlying TSH-induced liver triglyceride accumulation, involved that TSH, through its receptor TSHR, triggered hepatic SREBP-1c activity via the cAMP/PKA/PPAR alpha pathway associated with decreased AMPK, which further increased the expression of genes associated with lipogenesis. Conclusions: TSH increased the hepatic triglyceride content, indicating an essential role for TSH in the pathogenesis of NAFLD. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available